Skip to main content

'Robust' immune response seen in 'mix and match' Covid vaccine study

Mixing and matching Covid vaccines made by Pfizer-BioNTech and AstraZeneca-Oxford generates a "robust" immune response, a study led by Oxford University found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.